课题基金 / 基金详情

INTERLEUKIN-5 RECEPTOR IN COMPLEX WITH INTERLEUKIN-5

INTERLEUKIN-5 RECEPTOR IN COMPLEX WITH INTERLEUKIN-5
与 INTERLEUKIN-5 复合的 INTERLEUKIN-5 受体
批准号:
7358880
负责人:
Patrick J Loll
金额:
$0.36万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-07-01 至 2007-06-30

项目摘要

项目成果

Patrick J Loll的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Interleukin 5 (IL5) is the major hematopoietic cytokine responsible for differentiation, proliferation, migration, and activation of eosinophils. Eosinophils play key roles in the innate immune response and are also important players in pathological states such as asthma. IL5 acts on eosinophils through a cell surface receptor that contains alpha and beta chains, with alpha being primarily responsible for ligand binding and beta for signal transduction. As a first step in understanding how IL5 recruits alpha and beta chains and assembles them into a complex competent for intracellular signaling, we have crystallized the complex of IL5 with the extracellular domain of the receptor alpha chain. Our collaborators in the Chaiken laboratory have many years of experience in studying IL5-receptor interactions, and our structure will prove extremely useful in evaluating the data they have amassed concerning the development of agonists and antagonists and the effects of mutagenesis. Our long term goals include the crystallization of the IL5-alpha-beta complex, crystallization of the receptor with various peptide agonists and antagonists, and correlation of our structural results with functional data on receptor assembly acquired by the Chaiken group. A thorough structural and mechanistic understanding of how receptor assembly proceeds and leads to signaling will prove useful in the development of therapeutics for allergic inflammations such as asthma.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Antibiotic Recognition and Signaling in Vancomycin-Resistant Enterococci (VRE)
  • 批准号:
    10304192
  • 项目类别:
  • 资助金额:
    $38.87万
  • 财政年份:
    2019
  • 负责人:
    Patrick J Loll
  • 依托单位:
Antibiotic Recognition and Signaling in Vancomycin-Resistant Enterococci (VRE)
  • 批准号:
    10520037
  • 项目类别:
  • 资助金额:
    $38.87万
  • 财政年份:
    2019
  • 负责人:
    Patrick J Loll
  • 依托单位:
Antibiotic Recognition and Signaling in Vancomycin-Resistant Enterococci (VRE)
  • 批准号:
    10062476
  • 项目类别:
  • 资助金额:
    $38.87万
  • 财政年份:
    2019
  • 负责人:
    Patrick J Loll
  • 依托单位:
Novel anti-HIV compounds targeting the HIV-1 matrix protein
  • 批准号:
    10196947
  • 项目类别:
  • 资助金额:
    $55.51万
  • 财政年份:
    2018
  • 负责人:
    Patrick J Loll
  • 依托单位:
国内基金
海外基金
Succinate-Succinate Receptor介导的代谢反应在正畸牙根吸收中的作用
  • 批准号:
    82371007
  • 项目类别:
    面上项目
  • 资助金额:
    48万元
  • 批准年份:
    2023
  • 负责人:
    雷浪
  • 依托单位:
Leptin receptor阳性细胞通过分泌Hedgehog蛋白调控椎间盘退变及修复的谱系研究
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    52万元
  • 批准年份:
    2022
  • 负责人:
    傅强
  • 依托单位:
丹参酮ⅡA通过靶向TRAIL-receptor和ULBPs增强NK细胞抗非小细胞肺癌效应的作用及分子机制研究
  • 批准号:
    81903932
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2019
  • 负责人:
    龚陈媛
  • 依托单位:
白介素-1受体相关激酶(Interleukin-1 receptor associated kinase,IRAK)-M调节哮喘气道炎症异质性和气道重塑以及相关机制的研究